US Patent Issued to ACCENDATECH LUOYANG on Sept. 8 for "Application of sesquiterpene lactone in preparing drug for treating optic neuritis" (Chinese Inventors)

ALEXANDRIA, Va., Sept. 8 -- United States Patent no. 12,728,112, issued on Sept. 8, was assigned to ACCENDATECH LUOYANG Co. LTD. (Luoyang, China).

"Application of sesquiterpene lactone in preparing drug for treating optic neuritis" was invented by Hongen Li (Henan, China), Jianmiao Gong (Luoyang, China), Shiqi Bao (Luoyang, China) and Xuemei Zhang (Luoyang, China).

According to the abstract* released by the U.S. Patent & Trademark Office: "A sesquiterpene lactone compound is used in preparing a drug for treating optic neuritis. The sesquiterpene lactone compound and a pharmaceutically acceptable auxiliary material are prepared into a drug. ACT001 can effectively inhibit the inflammatory response of microglia, and can significantly reduce ...